Abiogen
Pisa, Italy· Est. 1997
Over time it has consolidated itself as a reference for the medical class, especially in the therapeutic areas that traditionally characterize its activity: bone metabolism, hypovitaminosis D, pain, viscosupplementation, dermatology, respiratory and diabetology.
Private Company
Total funding raised: $13M
About
Over time it has consolidated itself as a reference for the medical class, especially in the therapeutic areas that traditionally characterize its activity: bone metabolism, hypovitaminosis D, pain, viscosupplementation, dermatology, respiratory and diabetology.
Small Molecules
Funding History
2Total raised:$13M
Series A$10MJun 15, 2021
Seed$3MMar 15, 2019